A federal district court in Massachusetts denied Abiomed Inc., Abiomed R&D Inc., and Abiomed Europe GmbH’s motion for partial summary judgment of no infringement under the doctrine of equivalents in Maquet Cardiovascular LLC’s patent infringement action relating to a patent for intravascular blood pumps. The court found that Maquet raised genuine disputes about whether the differential and optical pressure sensors in Abiomed’s products were equivalent to the fluid-column pressure sensor claimed in the patent, based on expert testimony that must be evaluated at trial.
This summary was produced by Bloomberg Law Automation and edited by Bloomberg Law staff
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.